Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 1;18(9):1111-1112.
doi: 10.2215/CJN.0000000000000264. Epub 2023 Aug 9.

Iron Repletion for Patients with Heart Failure and Kidney Dysfunction

Daniel W Coyne  1
Affiliations
Editorial

Iron Repletion for Patients with Heart Failure and Kidney Dysfunction

Daniel W Coyne. Clin J Am Soc Nephrol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

D.W. Coyne has been an investigator and consultant for GSK, makers of a HIF-PHI, and has previously been a consultant to IV iron manufacturers. D.W. Coyne reports consultancy for Akebia, AstraZeneca, Boehringer/Lilly, Daicho Sankyo, FMC-RTG, GSK, Medibeacon, Otsuka, Travere, and Unicycive; research funding from AstraZeneca; and honoraria from Travere.

Comment on

References

    1. Macdougall IC Ponikowski P Stack AG, et al. . Ferric carboxymaltose in iron-deficient patients with hospitalized heart failure and reduced kidney function. Clin J Am Soc Nephrol. 2023;18(9):1124–1134. doi:10.2215/CJN.0000000000000223 - DOI - PMC - PubMed
    1. Ponikowski P Kirwan BA Anker SD, et al. . Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396(10266):1895–1904. doi:10.1016/s0140-6736(20)32339-4 - DOI - PubMed
    1. Pfeffer MA Burdmann EA Chen CY, et al. . A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361(21):2019–2032. doi:10.1056/nejmoa0907845 - DOI - PubMed
    1. Singh AK Carroll K McMurray JJV, et al. . Daprodustat for the treatment of anemia in patients not undergoing dialysis. N Engl J Med. 2021;385(25):2313–2324. doi:10.1056/nejmoa2113380 - DOI - PubMed
    1. Coyne DW. The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial. Kidney Int. 2012;82(2):235–241. doi:10.1038/ki.2012.76 - DOI - PMC - PubMed

LinkOut - more resources